Trial Information

Summary: A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).

Participants must meet the following criteria:

• Females 45-75 years old
• Five years postmenopausal
• Have mild to moderate osteoporosis (BMD T-Score from -2.0 to -4.0)
• Must be willing to have a non-invasive bone density test (BMD)
• Not be on any osteoporosis medications (e.g. Didrocal, Fosamax, Actonel, Hormone Replacement Therapy)
• Capable of understanding and giving written, voluntary informed consent
• Able to come to the study clinic for your visits
• Have no more than one fragility fracture

For further information, kindly call the nearest study coordinator:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.